• Explore /
  • Poster
  • / Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels to predict efficacy of bevacizumab in metastatic colorectal cancer patients receiving first-line chemotherapy.

Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels to predict efficacy of bevacizumab in metastatic colorectal cancer patients receiving first-line chemotherapy.

Abstract Poster

Authors

null

Mitsukuni Suenaga

Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

Mitsukuni Suenaga , Shu Cao , Wu Zhang , Yan Ning , Satoshi Okazaki , Martin D. Berger , Yuji Miyamoto , Marta Schirripa , Roel Gopez Jr., Elizabeth Melendez , Shivani Soni , Afsaneh Barzi , Toshiharu Yamaguchi , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Citation

J Clin Oncol 35, 2017 (suppl; abstr 11564)

DOI

10.1200/JCO.2017.35.15_suppl.11564

Abstract #

11564

Poster Bd #

264

Abstract Disclosures

Similar Posters

First Author: Eric Francois

First Author: Kathrin Heinrich

First Author: Satoshi Yuki

First Author: Jingyuan Wang